Moonlake Immunot shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Moonlake Immunot
Tip: Access up to 7 years of quarterly data
All positions including Moonlake Immunot held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Moonlake Immunot by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $34M | 1.8M | 18.64 |
| 2025-06-30 | $15M | 314k | 47.20 |
| 2025-03-31 | $12M | 316k | 39.07 |
| 2024-12-31 | $17M | 315k | 54.15 |
| 2024-09-30 | $18M | 349k | 50.42 |
| 2024-06-30 | $15M | 343k | 43.97 |
| 2024-03-31 | $15M | 296k | 50.23 |
| 2023-09-30 | $17M | 294k | 57.00 |
| 2023-06-30 | $15M | 295k | 51.00 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management